Report Overview
Summary
Molecular Partners AG (Molecular Partners) is a biopharmaceutical company that offers biological drugs. The company's advanced pipeline products comprise abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet age-related macular degeneration. It develops drugs on DARPin base technology and other product candidates. Molecular Partners develops products for ophthalmic conditions, cancer, immune disorders and other indications. The company also offers clinical trial services. It has partnership with pharmaceutical companies to strengthen drug platforms through in-house development, licensing and collaboration. Molecular Partners is headquartered in Zurich, Switzerland.
Molecular Partners AG (MOLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Molecular Partners AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Molecular Partners AG, Medical Devices Deals, 2011 to YTD 2017 9
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Molecular Partners AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Molecular Partners Reinforces Partnership with Allergan 11
Allergan Enters Into Co-Development Agreement With Molecular Partners 12
Molecular Partners Enters Into Research Agreement With Janssen Biotech 13
Licensing Agreements 14
Allergan Enters Into Licensing Agreement With Molecular Partners 14
Allergan Enters Into Licensing Agreement With Molecular Partners For MP0112 15
Equity Offering 16
Molecular Partners Raises USD31.7 Million in Private Placement of Shares 16
Molecular Partners Announces Partial Exercise of Underwriter’s Option for IPO for USD108 Million 17
Molecular Partners AG - Key Competitors 19
Molecular Partners AG - Key Employees 20
Molecular Partners AG - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Feb 09, 2017: Molecular Partners reports preliminary unaudited key financials for 2016: Advancements across all therapeutic areas – Ongoing strong cash position 22
Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 24
Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners 27
Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016 29
Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015 31
Corporate Communications 34
Apr 12, 2017: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to stand for re-election as member of the Board of Directors at the Annual General Meeting 2017 34
Nov 07, 2016: Molecular Partners Announces Management Change 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Molecular Partners AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Molecular Partners AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Molecular Partners AG, Deals By Therapy Area, 2011 to YTD 2017 8
Molecular Partners AG, Medical Devices Deals, 2011 to YTD 2017 9
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Molecular Partners Reinforces Partnership with Allergan 11
Allergan Enters Into Co-Development Agreement With Molecular Partners 12
Molecular Partners Enters Into Research Agreement With Janssen Biotech 13
Allergan Enters Into Licensing Agreement With Molecular Partners 14
Allergan Enters Into Licensing Agreement With Molecular Partners For MP0112 15
Molecular Partners Raises USD31.7 Million in Private Placement of Shares 16
Molecular Partners Announces Partial Exercise of Underwriter’s Option for IPO for USD108 Million 17
Molecular Partners AG, Key Competitors 19
Molecular Partners AG, Key Employees 20
List of Figures
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Molecular Partners AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Molecular Partners AG, Medical Devices Deals, 2011 to YTD 2017 9